Predicting the responder for pralatrexate against PTCL: a post hoc analysis of PDX-JP1 study

被引：0
|
作者：
Shimazu, Y. [1 ,2 ,3 ]
Kitawaki, T. [3 ]
Tonai, T. [4 ]
Floris, D. [5 ]
Takaori-Kondo, A. [3 ]
机构：
[1] Kyoto Univ Hosp, Kyoto Innovat Ctr Next Generat Clin Trials & iPS, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Early Clin Dev, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan
[4] Mundipharma KK, Med Excellence Dept, Tokyo, Japan
[5] Exact Sci, Baar, Switzerland
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.658
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O16-2
引用
收藏
页码：S1324 / S1324
页数：1
相关论文
共 50 条
  • [41] Performance of Doppler-Based Resistive Index and Semiquantitative Renal Perfusion in Predicting Persistent Acute Kidney Injury According to Operator Experience: Post Hoc Analysis of a Prospective Multicenter Study*
    Saade, Anastasia
    Bourmaud, Aurelie
    Schnell, David
    Darmon, Michael
    CRITICAL CARE MEDICINE, 2022, 50 (04) : E361 - E369
  • [42] EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE, WITH 4 OR <4 POOR PROGNOSTIC FACTORS: A POST HOC ANALYSIS OF THE FINCH 1 STUDY
    Combe, B.
    Tanaka, Y.
    Buch, M. H.
    Burmester, G. R.
    Bartok, B.
    Pechonkina, A.
    Han, L.
    Emoto, K.
    Kano, S.
    Hendrikx, T.
    Aletaha, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 632 - 632
  • [43] Repair of erosions occurs almost exclusively in damaged joints without swelling: Post hoc analysis of radiographic data from year 1 of the tempo study
    van der Heijde, D.
    Lukas, C.
    Fatenejad, S.
    Landewe, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 54 - 54
  • [44] GERMAN GOBOLUS STUDY - POST-HOC ANALYSIS OF GLYCEMIC CONTROL USING ISCCGM IN PATIENTS WITH TYPE 1 DIABETES IN ASSOCIATION WITH BASAL INSULIN UTILIZATION
    Ziegler, R.
    Schweitzer, M.
    Kipper, S.
    Gollan, R.
    Westrup, D.
    Danne, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A5 - A5
  • [45] KarXT treatment improves cognitive performance in cognitively impaired patients with schizophrenia: a post-hoc analysis of the phase 2 EMERGENT-1 study
    Sauder, C.
    Allen, L.
    Baker, E.
    Granger, K.
    Brier, A.
    Kavanagh, S.
    Marcus, R.
    Paul, S.
    Miller, A.
    Brannan, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S580 - S581
  • [46] Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study
    Combe, Bernard G.
    Tanaka, Yoshiya
    Buch, Maya H.
    Nash, Peter
    Burmester, Gerd R.
    Kivitz, Alan J.
    Bartok, Beatrix
    Pechonkina, Alena
    Xia, Katrina
    Emoto, Kahaku
    Kano, Shungo
    Hendrikx, Thijs K.
    Landewe, Robert B. M.
    Aletaha, Daniel
    RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 53 - 70
  • [47] Tildrakizumab efficacy by metabolic syndrome status in psoriasis: Post hoc analysis of 3-year data from the phase 3 reSURFACE 1 study
    Lebwohl, Mark G.
    Gottlieb, Alice B.
    Mendelsohn, Alan M.
    Parno, Jeff
    Rozzo, Stephen J.
    Menter, Martin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB51 - AB51
  • [48] Patient characteristics from a post hoc analysis of nascent geographic atrophy progression following treatment with avacincaptad pegol from the GATHER1 study
    Danzig, Carl J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [49] Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study
    Bernard G. Combe
    Yoshiya Tanaka
    Maya H. Buch
    Peter Nash
    Gerd R. Burmester
    Alan J. Kivitz
    Beatrix Bartok
    Alena Pechonkina
    Katrina Xia
    Kahaku Emoto
    Shungo Kano
    Thijs K. Hendrikx
    Robert B. M. Landewé
    Daniel Aletaha
    Rheumatology and Therapy, 2023, 10 : 53 - 70
  • [50] Efficacy and Safety of Filgotinib in Patients with Inadequate Response to Methotrexate, with 4 or < 4 Poor Prognostic Factors: A Post Hoc Analysis of the FINCH 1 Study
    Combe, Bernard
    Tanaka, Yoshiya
    Buch, Maya
    Burmester, Gerd
    Bartok, Beatrix
    Pechonkina, Alena
    Han, Ling
    Emoto, Kahaku
    Kano, Shungo
    Hendrikx, Thijs
    Aletaha, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1816 - 1818
12345